New daily pill aims to save sight in diabetic eye disease
Disease control
Not yet recruiting
This study tests an oral medication, CU06-1004, for people with diabetic macular edema (DME), a condition that causes vision loss. About 156 participants will take either a low dose, high dose, or placebo pill daily for 24 weeks. The goal is to see if the drug improves vision and…
Phase: PHASE2 • Sponsor: Curacle Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC